Arch Therapeutics Inc (ARTH)

[jsmith123343]

My questions to management -

[1] why the delay for CE ? Do they want to get the subgroup information, which may show some subgroups performed better ?

[2] When are they planning to start trials for internal surgeries. Think this will be the big bet, as it clearly shows internal surgeries in rats was very good, easy to use etc.

[3] What is plan for US FDA PMA ? They are saying they are planning for it.